Methylphenidate in ADHD Preschoolers with Disability

J Gordon Millichap

doi:10.15844/pedneurbriefs-13-7-12

Methylphenidate in ADHD Preschoolers with Disability

Pediatric Neurology Briefs

Volume 13 (1999): Issue 7

By: J Gordon Millichap

Open Access

|Jul 1999

Abstract

The safety and efficacy of methylphenidate (MPH), 0.3 and 0.6 mg/kg, in 11 preschool children (aged 4-5 years) with developmental disabilities and attention deficit hyperactivity disorder (ADHD) were determined in a double-blind, placebo-controlled, crossover study at the Western Psychiatric Institute, University of Pittsburgh, PA.

References

Handen BL Feldman HM Lurier A Murray PJ Efficacy of methylphenidate among preschool children with developmental disabilities and ADHD J Am Acad Child Adolesc Psychiatry 1999 Jul 38 7 805 812 10.1097/00004583-199907000-00009 10405497
Open DOI Search in Google Scholar Back to article
Jensen PS Kettle L Roper MT Sloan MT Dulcan MK Hoven C Are stimulants overprescribed? Treatment of ADHD in four U.S. communities J Am Acad Child Adolesc Psychiatry 1999 Jul 38 7 797 804 10.1097/00004583-199912000-00019 10405496
Open DOI Search in Google Scholar Back to article

Articles in this issue

DOI: https://doi.org/10.15844/pedneurbriefs-13-7-12 | Journal eISSN: 2166-6482

Journal RSS Feed

Language: English

Page range: 56 - 56

Published on: Jul 1, 1999

Published by: Pediatric Neurology Briefs Publishers

In partnership with: Paradigm Publishing Services

Keywords:

Methylphenidate,

Attention Deficit Hyperactivity Disorder,

Double-Blind

© 1999 J Gordon Millichap, published by Pediatric Neurology Briefs Publishers
This work is licensed under the Creative Commons Attribution 4.0 License.

Volume 13 (1999): Issue 7